[Anti-beta-2-microglobulin antibodies in systemic lupus erythematosus]. 1997

J de A Kochen, and M R Nobre, and R M de Oliveira, and N H Yoshinari
Disciplina de Reumatologia, Faculdade de Medicina, Universidade de São Paulo.

The aim of this work was the study of 88 patients with SLE for clinical, laboratorial and demographical parameters. The patients sera were assayed for the presence of anti-beta-2-microglobulin antibodies by ELISA. These spectrofotometric results were converted in a standard-deviation unity in relation to the average of 29 control individuals values. It was established a cut-off of 2.5 standard-deviation in order to determine the limit of normality as well as the cut-off of 10 standard deviation was chosen in order to defined the higher values. Several statistical significant associations were observed between the anti-beta-2-microgobulin and the clinical and laboratorial parameters. The clinical applications of those associations were determined by the predictive value. It was only considered the values greater then 75%. The negative predictive values found in the lower cut-off were 92% to ANA (homogeneous-peripheral pattern), 89% to high levels CIC, 81% to mucocutaneous vasculitis and 80% to depressed CH50 levels. The positive predictive values found in 88% to high level of mucoprotein, 83% to mucocutaneous vasculitis, 83% to the onset-disease-time lower six years and 78% to limphopenia. Special attention may be paid to the high sensibility and specificity of the anti-beta-2-microglobulin test to some of the parameters in the evaluation of the disease activity, mainly in mucocutaneous vasculitis.

UI MeSH Term Description Entries
D008180 Lupus Erythematosus, Systemic A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Libman-Sacks Disease,Lupus Erythematosus Disseminatus,Systemic Lupus Erythematosus,Disease, Libman-Sacks,Libman Sacks Disease
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001323 Autoantibodies Antibodies that react with self-antigens (AUTOANTIGENS) of the organism that produced them. Autoantibody
D001613 beta 2-Microglobulin An 11-kDa protein associated with the outer membrane of many cells including LYMPHOCYTES. It is the small subunit of MHC CLASS I MOLECULES. Association with beta 2-microglobulin is generally required for the transport of class I heavy chains from the endoplasmic reticulum to the cell surface. Beta 2-microglobulin is present in small amounts in serum, CEREBROSPINAL FLUID, and urine of healthy individuals, and to a much greater degree in the urine and plasma of patients with tubular PROTEINURIA, renal failure, or kidney transplants. Thymotaxin,beta 2 Microglobulin

Related Publications

J de A Kochen, and M R Nobre, and R M de Oliveira, and N H Yoshinari
April 1988, Revista clinica espanola,
J de A Kochen, and M R Nobre, and R M de Oliveira, and N H Yoshinari
December 1986, The Journal of rheumatology,
J de A Kochen, and M R Nobre, and R M de Oliveira, and N H Yoshinari
November 1985, Clinical immunology and immunopathology,
J de A Kochen, and M R Nobre, and R M de Oliveira, and N H Yoshinari
September 2002, Medicina clinica,
J de A Kochen, and M R Nobre, and R M de Oliveira, and N H Yoshinari
February 1986, The Journal of rheumatology,
J de A Kochen, and M R Nobre, and R M de Oliveira, and N H Yoshinari
October 1977, Immunology,
J de A Kochen, and M R Nobre, and R M de Oliveira, and N H Yoshinari
February 1979, Journal of immunology (Baltimore, Md. : 1950),
J de A Kochen, and M R Nobre, and R M de Oliveira, and N H Yoshinari
January 2014, Sao Paulo medical journal = Revista paulista de medicina,
J de A Kochen, and M R Nobre, and R M de Oliveira, and N H Yoshinari
January 1986, Scandinavian journal of rheumatology,
J de A Kochen, and M R Nobre, and R M de Oliveira, and N H Yoshinari
April 2010, The American journal of the medical sciences,
Copied contents to your clipboard!